Rigel Pharmaceuticals Inc (RIGL) — Cash Flow Reinvestment Rate
Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow Reinvestment Rate of 2.93x as of March 2026, reinvesting $7.97 Million (capex $0.00 plus investments $-7.97 Million) from operating cash flow of $2.73 Million. Check Rigel Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Rigel Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2025)
Historical reinvestment intensity for Rigel Pharmaceuticals Inc across 4 annual periods. Explore Rigel Pharmaceuticals Inc (RIGL) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Rigel Pharmaceuticals Inc (2010–2025)
Year-by-year capital reinvestment analysis for Rigel Pharmaceuticals Inc. For live market cap and broader valuation context, see Rigel Pharmaceuticals Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.22x | $92.36 Million | $75.66 Million | $0.00 | ▲ +748.9% |
| 2024 | 0.14x | $4.53 Million | $31.47 Million | $396.00K | ▼ -98.9% |
| 2021 | 13.62x | $80.04 Million | $5.88 Million | $627.00K | ▲ +17778.1% |
| 2010 | 0.08x | $3.56 Million | $46.74 Million | $3.56 Million | — |